Primary prevention for acute kidney injury in ambulatory patients
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.contributor.author | Musso, Carlos G. | |
| dc.contributor.author | Rosell, Camila | |
| dc.contributor.author | Gonzalez-Torres, Henry | |
| dc.contributor.author | Ordonez, Juan D. | |
| dc.contributor.author | Aroca-Martinez, Gustavo | |
| dc.date.accessioned | 2020-07-22T16:10:04Z | |
| dc.date.available | 2020-07-22T16:10:04Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Acute kidney injury (AKI) is a heterogeneous group of conditions characterized by a sudden decrease in glomerular filtration rate (GFR), which usually induces the accumulation of nitrogenous-waste substances in the blood. It is expressed as an increase in serum creatinine levels (≥ 0.3 mg/dl within 48 hours or ≥1.5 times from baseline within the previous 7 days) or by a urine volume reduction of ˂0.5 ml/kg/h in 6 hours [1]. AKI is a relevant condition since it is usually associated with 1–7% and 30–50% of hospital and intensive care unit (ICU) admissions, respectively; showing a significant morbidity-mortality rate, and progression to chronic kidney disease (CKD) [1–7]. Even though many strategies have been proposed to achieve an early AKI diagnosis (e.g. novel biomarkers, informatics alarms), and an AKI effective treatment (e.g. renal protective drugs, biocompatible renal replacement therapies), both objectives remain unachieved; therefore, AKI prevention is currently the best ‘therapeutic’ strategy for this condition. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.doi | https://doi.org/10.1080/00325481.2020.1795484 | |
| dc.identifier.issn | 19419260 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/6232 | |
| dc.identifier.url | https://www.tandfonline.com/doi/abs/10.1080/00325481.2020.1795484?tab=permissions&scroll=top | |
| dc.language.iso | eng | eng |
| dc.publisher | Taylor & Francis | eng |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Postgraduate Medicine | eng |
| dc.source | Vol. 132, (2020) | |
| dc.subject | Acute kidney injury | eng |
| dc.subject | Prevention | eng |
| dc.subject | Nephrotoxicity | eng |
| dc.title | Primary prevention for acute kidney injury in ambulatory patients | eng |
| dc.type.driver | info:eu-repo/semantics/article | eng |
| dc.type.spa | Artículo científico | spa |
| dcterms.references | KDIGO Clinical Practice. Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(Supplement 1):124–138. | eng |
| dcterms.references | Blanco VE, Hernandorena CV, Scibona P, et al. Acute kidney injury pharmacokinetic changes and its impact on drug prescription. Healthcare (Basel). 2019 Jan 14;7(1):E10. | eng |
| dcterms.references | Musso CG, Terrasa S, Ciocchini M, et al. Looking for a better definition and diagnostic strategy for acute kidney injury: a new proposal. Arch Argent Pediatr. 2019 Feb 1;117(1):4–5. | eng |
| dcterms.references | Musso C, Aguilera J, Otero C, et al. Informatic nephrology. Int Urol Nephrol. 2013 Aug;45(4):1033–1038. | eng |
| dcterms.references | Negi S, Koreeda D, Kobayashi S, et al. Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies. Semin Dial. 2018 Sep;31(5):519–527. | eng |
| dcterms.references | Malhotra R, Siew E. Biomarkers for the early detection and prognosis of acute kidney injury. Clin J Am Soc Nephrol. 2017 Jan 6;12 (1):149–173. | eng |
| dcterms.references | Koyner J, Adhikari R, Edelson D, et al. Development of a multicenter ward–based AKI prediction model. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1935–1943. Published online 2016 Sep 15. | eng |
| dcterms.references | Meersch M, Schmidt C, Hoffmeier A, et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43(11):1551–1561. Published online 2017 Jan 21 | eng |
| dcterms.references | Koyner J, Davison D, Brasha-Mitchell E, et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015 Aug;26(8):2023–2031. Published online 2015 Feb 5 | eng |
| dcterms.references | Silver SA, Goldstein SL, Harel Z, et al. Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Can J Kidney Health Dis. 2015;(2):36. Published online 2015 Oct 6. | eng |
| dcterms.references | Menon S, Goldstein S, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant. 2016 Apr;31(4):586–594. Published online 2016 Feb 2 | eng |
| dcterms.references | Chao C-T, Tsai H-B, Chiang C-K, et al., COGENT study group. Acute kidney injury as a risk factor for diagnostic discrepancy among geriatric patients: a pilot study. Sci Rep. 2016;6:38549. Published online 2016 Dec 16. | eng |
| dcterms.references | Musso CG, Vilas M. Water, electrolyte, and acid-base disorders in the elderly. In: Musso CG, Jauregui JR, Macías-Núñez JF, et al., editors. Clinical nephrogeriatrics. An evidence-based guide. Cham: Springer; 2019. p. 43–62. | eng |
| dcterms.references | Musso CG, Vilas M. Nephroprevention in very old patients. Rev Colomb Nefrol. 2015;2(2):131–136. | eng |
| dcterms.references | De Broe ME, Porter GA, Bennett WM, et al. Clinical nephrotoxins. Renal injury from drugs and chemicals. New York: Springer; 2008. | eng |
| dcterms.references | Levey AS, James MT. Acute Kidney Injury. Ann Intern Med. 2018 Jun 5;168(11):837. | eng |
| dcterms.references | Chawla LS, Bellomo R, Bihorac A, et al. Acute disease quality initiative workgroup 16. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017 Apr;13(4):241–257. | eng |
| dcterms.references | Rennke H, Denker B. Renal pathophysiology. Phiadelphia: Lippincott Williams & Wilkins; 2007. | eng |
| dcterms.references | Market Juri A. Prevention of kidney disease: is it a reachable chimera? Rev Colomb Nefrol. 2016;3(1):1–3. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | eng |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Primarypreventifforacutekidneinjurambulpatients.pdf
- Tamaño:
- 518.02 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 381 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: